CellDrop Biosciences develops hydrogel-based point-of-care diagnostics and targeted biomaterial delivery technology.
CellDrop Biosciences develops hydrogel-based point-of-care diagnostics and targeted biomaterial delivery technology. The company was established in 2017 and is headquartered in Laramie, Wyoming.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 23, 2021 | Grant | $256K | 1 |
National Science Foundation
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Science Foundation
|
Yes | Grant |